Differential requirements of NMDAR and VDCC for Aβ-induced declustering of Homer1b and Shank1. by Francesco Roselli (211670)

“…NMDA alone significantly reduced Homer (75.1±8.8%, p<0.05) and a further decrease was observed after NMDA+Aβ cotreatment (50.2±5.2% of untreated control). …”

A serine/threonine phosphatase and kinase oppositely regulate hemolytic activity of <i>S. aureus</i>. by Kellie Burnside (247478)

“…<p>(<b>A</b>) A transposon (Tn5EZ) insertion in <i>stp1</i> (53E12) decreased hemolytic activity whereas the strain with the Tn5EZ insertion in <i>stk1</i> (60C1) increased hemolytic activity compared to the isogenic WT Newman. …”

SPAP gives a sustained benefit to pumping favoring tighter membranes and allowing free living. by Víctor Sojo (613931)

“…<p>(A) The combination of SPAP with 5% H⁺ pump gives a sustained increase in −ΔG as membrane permeability decreases, for the first time favoring the evolution of modern proton-tight phospholipid membranes. …”

Image2_Clinical management of finger joint capsulitis/synovitis in a rock climber.jpg by Jared Vagy (15891431)

“…After 6 weeks, the climber's pain 24 h after climbing, which was rated on a visual analog pain scale (VAS), decreased from 5.5/10 to 1.5/10 and 0/10 at the 12-month follow-up. …”

Image1_Clinical management of finger joint capsulitis/synovitis in a rock climber.jpg by Jared Vagy (15891431)

“…After 6 weeks, the climber's pain 24 h after climbing, which was rated on a visual analog pain scale (VAS), decreased from 5.5/10 to 1.5/10 and 0/10 at the 12-month follow-up. …”

Image1_Clinical management of finger joint capsulitis/synovitis in a rock climber.jpg by Jared Vagy (15891431)

“…After 6 weeks, the climber's pain 24 h after climbing, which was rated on a visual analog pain scale (VAS), decreased from 5.5/10 to 1.5/10 and 0/10 at the 12-month follow-up. …”

Image2_Clinical management of finger joint capsulitis/synovitis in a rock climber.jpg by Jared Vagy (15891431)

“…After 6 weeks, the climber's pain 24 h after climbing, which was rated on a visual analog pain scale (VAS), decreased from 5.5/10 to 1.5/10 and 0/10 at the 12-month follow-up. …”

Effects of 1,25(OH)₂D₃ on transendothelial electrical resistance (TEER) in bEnd.3 cells under hypoxia/reoxygenation (H/R). by Soonmi Won (713581)

“…Values are represented as mean ± s.e.m. <b>(B-C)</b> Pretreatment with vitamin D receptor antagonist pyridoxal 5’-phosphate (P5P) decreased the effect of Vit D (with an observed maximum protective dose of 100 nM) on H/R-induced TEER reduction and 40 kDa FITC-dextran increase in bEnd.3 cell monolayers. …”

Data_Sheet_1_Mindfulness Training for Primary Care for Portuguese-Speaking Immigrants: A Pilot Study.docx by Marcelo Trombka (11411288)

“…All survey finishers would recommend the program to a friend, found the program helpful, and rated the overall program as “very good” or “excellent,” and 93% would participate again, with satisfaction mean scores between 4.6 and 5 (Likert scale 0–5). …”

A3H HapI showed an impaired ability to package into HIV-1 virions. by Anjie Zhen (313428)

“…<p>To compare anti-viral activity and packaging of A3H HapI and HapII, pNL4-3Δvif was transfected with decreasing doses of A3H HapII and HapI. …”

Non-radioactive phosphorylation assays. by Lech Kaczmarczyk (587512)

“…(<b>B</b>) MALDI-TOF-MS analysis of CPEB3-derived peptides phosphorylated by PKA-C. A mass shift corresponding to incorporation of 1 or 2 phosphates is observed, as compared with no-kinase control. …”

Highly Emissive <i>ortho</i>-Donor–Acceptor Triarylboranes: Impact of Boryl Acceptors on Luminescence Properties by Juhee Kim (210266)

“…Notably, a decrease in PLQY with an increase in the polarity of the solvent is less sensitive for the cyclic boryl-containing <b>1</b> and <b>2</b>. …”

Age-specific incidence, treatment, and survival trends in esophageal cancer: a Dutch population-based cohort study by Ali Al-Kaabi (7437800)

“…Treatment trends and relative survival rates (RSR) were estimated by age and stage grouping.</p> <p>A total 59,584 patients were included. In adults <50 years, EAC incidence tripled (mean increase per year: males 1.5%, females 3%), while the incidence of ESCC decreased (mean decrease per year: males −5.3%, females −4.3%). …”

Additional file 6 of Impact of seat position on survival outcomes and anatomically specific severe injury patterns in four-wheeled motor vehicle accidents: a retrospective cohort s... by Tasuku Uzawa (20678522)

High-fat diet and streptozotocin in the induction of type 2 diabetes mellitus: a new proposal by DIEGO A. DE MAGALHÃES (6509696)

“…Male Wistar rats (240-250g) were divided into a control group (commercial feed), and HF-STZ group, (66.5%-commercial feed, 13.5%-lard, and 20%-sugar). …”

Supplementary Material for: GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors? by Aristizabal Prada E.T. (3593792)

“…<b><i>Materials and Methods:</i></b> Human NET cell lines (BON1, QGP1, H727, and GOT1) were treated with different concentrations of AR-A014418 alone and in combination with lovastatin, everolimus, 5-fluorouracil (5-FU), and γ-irradiation. …”

Elimination of Schistosomiasis Transmission in Zanzibar: Baseline Findings before the Onset of a Randomized Intervention Trial by Stefanie Knopp (108848)

“…In Zanzibar, various institutions and stakeholders have joined forces to eliminate urogenital schistosomiasis within 5 years. We report baseline findings before the onset of a randomized intervention trial designed to assess the differential impact of community-based praziquantel administration, snail control, and behavior change interventions.…”

Flow diagram of the study population. by Juliana Portes (17357216)

“…There was a statistically significant (p < 0.02) improvement in "Exercise tolerance functions" over 12 months and also a statistically significant (p < 0.001) decrease in "Muscle strength functions" over 12 months. …”

Qualifier and level of commitment. by Juliana Portes (17357216)

“…There was a statistically significant (p < 0.02) improvement in "Exercise tolerance functions" over 12 months and also a statistically significant (p < 0.001) decrease in "Muscle strength functions" over 12 months. …”

Immunohistochemical staining for LAMP-1 (CD107a) of CT26.CL25 tumors. by Pawel Mroz (156435)

“…<p>A. non-treated control. B. negative control for staining. …”